Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

EDIT

EDIT News

Newswire

16:44

Editas Medicine Executives Sell Shares, CEO O'Neill Neil Sells 5603 Shares

06:45

Editas Medicine Posts Q4 Revenue of $7.5M, Analysts Boost Estimates

09:30

Editas Medicine Q3 Earnings: Surpasses Revenue Estimates, Shares Up 94.5% YTD

08:45

Editas Medicine shares rise 10.53% premarket after EDIT-401 shows >90% LDL-C reduction in NHPs and extended cash runway.

07:18

Editas Medicine reports Q3 2025 results, EDIT-401 progress, and extended cash runway.

View More

About EDIT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More